MK-1006

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetes Mellitus, Non-Insulin-DependentType 2 Diabetes

Phase 1

A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED)

TerminatedNCT00758680

Merck Sharp & Dohme LLCType 2 Diabetes

Start: 2008-08-31End: 2010-03-31Updated: 2016-02-05

MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)

CompletedNCT00791661

Merck Sharp & Dohme LLCDiabetes Mellitus, Non-Insulin-Dependent

Start: 2008-11-30End: 2009-03-31Updated: 2016-01-07